Taken together, our data suggest that an immune response triggered by the Tn antigen is very likely driven by the immune cell composition of the breast cancer microenviroment, particularly by specific subpopulations of macrophages, rather than by differences in levels of CLEC10A expression on immune cells. This evidence concerns the gene CLEC10A and breast cancer.